Braveheart Bio, Inc. ( NASDAQ:BRVE – Get Free Report )’s share price traded up 8.1% during trading on Thursday . The stock traded as high as $22.47 and last traded at $23.1990. Approximately 194,514 shares were traded during trading, a decline of 58% from the average session volume of 462,762 shares. The stock had previously closed at $21.46.
Analyst Ratings Changes A number of equities research analysts have weighed in on the stock. Cantor Fitzgerald began coverage on shares of Braveheart Bio in a research note on Monday, August 31st. They set an “overweight” rating and a $40.00 target price for the company. Jefferies Financial Group started coverage on Braveheart Bio in a report on Monday, August 31st. They issued a “buy” rating and a $48.00 price objective for the company. The Goldman Sachs Group began coverage on Braveheart Bio in a research report on Monday, August 31st. They set a “buy” rating and a $48.00 price objective for the company. Zacks Research upgraded Braveheart Bio to a “hold” rating in a research note on Tuesday, September 1st. Finally, Stifel Nicolaus started coverage on shares of Braveheart Bio in a research note on Monday, August 31st. They issued a “buy” rati...